• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Sanjeeva P. Kalva, MD


  • Kalva SP, Pectasides M, Yeddula K, Ganguli S, Blaszkowsky LS, Zhu AX.Factors affecting survival following chemoembolization with doxorubicin-eluting microspheres for inoperable hepatocellular carcinoma.J Vasc Interv Radiol. 2013 Feb;24(2):257-65.
  • Kalva SP, Iqbal SI, Yeddula K, Blaszkowsky LS, Akbar A, Wicky S, Zhu AX.Transarterial chemoembolization with Doxorubicin-eluting microspheres for inoperable hepatocellular carcinoma.Gastrointest Cancer Res. 2011 Jan;4(1):2-8.
  • Kalva SP, Yeddula K, Wicky S, Fernandez Del Castillo C, Warshaw AL.Angiographic Intervention in Patients With a Suspected Visceral Artery Pseudoaneurysm Complicating Pancreatitis and Pancreatic Surgery.Arch Surg. 2011 Feb 21.
  • Kalva SP, Salazar GM, Walker TG.Transjugular intrahepatic portosystemic shunt for acute variceal hemorrhage.Tech Vasc Interv Radiol. 2009 Jun;12(2):92-101. Review.
  • Kalva SP, Thabet A, Wicky S.Recent advances in transarterial therapy of primary and secondary liver malignancies.Radiographics.;28(1):101-17. Review.
  • McDonald DK, Kalva SP, Fan CM, Vasilyev A.Leiomyosarcoma of the uterus with intravascular tumor extension and pulmonary tumor embolism.Cardiovasc Intervent Radiol.;30(1):140-2.
  • Willett CG, Boucher Y, Duda DG, di Tomaso E, Munn LL, Tong RT, Kozin SV, Petit L, Jain RK, Chung DC, Sahani DV, Kalva SP, Cohen KS, Scadden DT, Fischman AJ, Clark JW, Ryan DP, Zhu AX, Blaszkowsky LS, Shellito PC, Mino-Kenudson M, Lauwers GY.Surrogate markers for antiangiogenic therapy and dose-limiting toxicities for bevacizumab with radiation and chemotherapy: continued experience of a phase I trial in rectal cancer patients.J Clin Oncol. 2005 Nov 1;23(31):8136-9.
  • Kalva SP, Sahani DV, Ryan D, Fischman AJ, Hahn PF, Mueller P, Saini S.Detection of liver metastases from gastrointestinal cancer: comparision of high resolution MnDPDP enhanced MRI and FDG-PET.Acad Radiol. 2005 May;12 Suppl 1:S17-20.
  • Sahani DV, Kalva SP, Fischman AJ, Kadavigere R, Blake M, Hahn PF, Saini S.Detection of liver metastases from adenocarcinoma of the colon and pancreas: comparison of mangafodipir trisodium-enhanced liver MRI and whole-body FDG PET.AJR Am J Roentgenol. 2005 Jul;185(1):239-46.
  • Sahani DV, Kalva SP, Hamberg LM, Hahn PF, Willett CG, Saini S, Mueller PR, Lee TY.Assessing tumor perfusion and treatment response in rectal cancer with multisection CT: initial observations.Radiology. 2005 Mar;234(3):785-92.
  • Sahani DV, Kalva SP, Tanabe KK, Hayat SM, O'Neill MJ, Halpern EF, Saini S, Mueller PR.Intraoperative US in patients undergoing surgery for liver neoplasms: comparison with MR imaging.Radiology. 2004 Sep;232(3):810-4.
  • Sahani DV, Kalva SP.Imaging the liver.Oncologist. 2004;9(4):385-97. Review.
  • Willett CG, Boucher Y, di Tomaso E, Duda DG, Munn LL, Tong RT, Chung DC, Sahani DV, Kalva SP, Kozin SV, Mino M, Cohen KS, Scadden DT, Hartford AC, Fischman AJ, Clark JW, Ryan DP, Zhu AX, Blaszkowsky LS, Chen HX, Shellito PC, Lauwers GY, Jain RK.Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer.Nat Med. 2004 Feb;10(2):145-7.
  • Sahani DV, Kalva SP, Hahn PF.Imaging of rectal cancer.Semin Radiat Oncol. 2003 Oct;13(4):389-402. Review.